Background: Morphine is widely used throughout the human life span. Several pharmacokinetic models have been proposed to predict how morphine clearance changes with weight and age. This study uses a large external data set to evaluate the ability of pharmacokinetic models to predict morphine doses.
Methods: A data set of morphine clearance estimates was created from published reports in premature neonates, full-term neonates, infants, children, and adults. This external data set was used to evaluate published models for morphine clearance as well as other models proposed for use in neonates and infants. Morphine clearance predictions were used to predict morphine dose rates to achieve similar target concentrations in all age groups.
Results: An allometric ¾ power model using weight combined with a sigmoid maturation model using postmenstrual age successfully predicted the morphine dose rate (within 25% of target) in all age groups except infants [predicted dose 30% under target (95% CI, 7-46%)]. Other published models based on empirical allometric scaling all made unacceptable predictions (>100% of target) in at least one age group.
Conclusions: Clearance based on empirical allometric scaling predicted unacceptable doses. Theory-based allometric scaling combined with a maturation function has been confirmed by external evaluation to provide a sound basis for describing clearance and predicting morphine doses in humans of all ages.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1460-9592.2011.03782.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics.
Fluids Barriers CNS
December 2024
Translational Pharmacokinetics/Pharmacodynamics Group (tPKPD), Department of Pharmacy, Uppsala University, Box 580, 75123, Uppsala, Sweden.
Background: Oxycodone, a widely used opioid analgesic, has an unbound brain-to-plasma concentration ratio (K) greater than unity, indicating active uptake across brain barriers associated with the putative proton-coupled organic cation (H/OC) antiporter system. With this study, we aimed to elucidate oxycodone's CNS disposition during lipopolysaccharide (LPS)-induced systemic inflammation in Sprague-Dawley rats.
Methods: Using brain microdialysis, we dynamically and simultaneously monitored unbound oxycodone concentrations in blood, striatum, lateral ventricle, and cisterna magna following intravenous administration of oxycodone post-LPS challenge.
Pharmacokinetic Modeling and Model-Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal Syndrome.
Clin Pharmacol Ther
November 2024
St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
The No-POPPY study (NCT03396588), a double-blind, randomized trial compared morphine with clonidine therapy for neonatal opioid withdrawal syndrome (NOWS) and found that the duration of treatment was similar across groups. This is significant because perinatal use of morphine has the potential for neurodevelopmental consequences. Still, the clonidine group reached symptom stabilization (Finnegan score (FS) < 8) later than the morphine group and had a more significant number of patients who required adjunct therapy.
View Article and Find Full Text PDFPeriarticular Injection With or Without Adductor Canal Block for Pain Control Following Total Knee Arthroplasty.
J Arthroplasty
October 2024
Department of Orthopaedic Surgery, Duke University, Durham, North Carolina.
Article Synopsis
- The study investigated the effectiveness of adductor canal blocks (ACBs) and periarticular injections (PAIs) for managing postoperative pain in total knee arthroplasty (TKA) patients, comparing these methods separately and in combination.
- Results showed that while initial pain scores were similar, those receiving PAIs alone had lower narcotic use and shorter hospital stays compared to those receiving ACBs alone.
- Overall, the findings suggest that PAIs provide advantageous postoperative outcomes, including better pain management and benefits for patient care efficiency.
The Effects of Opioid Administration on Infection: A Retrospective Cohort Study.
J Pharm Pract
February 2025
The University of Tennessee Medical Center, Knoxville, TN, USA.
() is a leading cause of healthcare-associated infections. Using opioids while infected with may hypothetically lead to reduced clearance of the organism and higher risk of progressing to severe or fulminant infection. The objective of this study was to determine if opioid use leads to worsening of infection.
View Article and Find Full Text PDFA Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study.
Adv Ther
September 2024
NorthStar Consulting, LLC, Davis, CA, USA.
Introduction: There is a medical need for a safe, effective nonopioid postoperative analgesic for older subjects, including those with mild to moderate renal impairment.
Methods: Participants (≥ 65 years) were stratified by no, mild, or moderate renal impairment defined as creatinine clearance 60-89 mL/min for mild and 30-59 mL/min for moderate. Subjects were randomized to receive a loading dose of 6.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!